We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for those who have been prescribed Paxlovid.
PTLFU and treatment delays and their associated demographic, clinical, and health system-related factors
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The objective of this study is to assess the incremental cost-effectiveness of 2 projects
PRIME is the Programme for Improving Mental Health Care
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
Studies in industrialised and resource-poor countries point to a higher risk of death in TB survivors
Barriers to innovation in medicines and medicinal technology and the opportunities for improvement: a study by Deloitte and partners.
UK, US and Canada regret Russia's lack of response to the Vienna Mechanism of March 2024 on prison conditions and call for immediate humanitarian release of Vladimir Kara-Murza.
First published during the 2022 to 2024 Sunak Conservative government
This research examined the documentation of torture and ill-treatment in Kenya, Nepal and Bangladesh.
The aim of this study was to examine if this training has improved patient retention in care
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).